CAR T-cell therapy to be funded for three lymphomas

Australia to be one of the few countries to manufacture the treatment

Chimeric antigen receptor (CAR) T-cell therapy for certain relapsed and refractory patients with three types of lymphoma will be publicly funded, Minister for Health Greg Hunt has announced.

Peter MacCallum Cancer Centre
The Peter MacCallum Cancer Centre in Melbourne.

Eligible patients will be certain adults with diffuse large B-cell lymphoma or the rarer conditions of transformed

Latest

Trending